Global Stem Cell Therapy Market Analysis 2018 - Forecast to 2025

Global Stem Cell Therapy Market Analysis 2018 - Forecast to 2025

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K., Spain and ROE), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), South America (Argentina, Brazil, Venezuela, Chile, and Peru) and Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, and Rest of MEA). Annual estimations and forecasts are provided from the year 2014 to 2025 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

  • Market Sizing estimations and forecasts across the given market segments
  • Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, )
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping of major market players
  • Company profiling covering the financials, recent activities and the future strategies


1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations
2 Executive Summary
3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Stem Cell Therapy Market by Type
5.1 Introduction
5.2 Allogeneic Stem Cell
5.3 Autologous Stem Cell
6 Stem Cell Therapy Market by Cell Source
6.1 Introduction
6.2 Embryonic SCs
6.3 Bone Marrow-Derived Mesenchymal SCs
6.4 Adipose Tissue-Derived Mesenchymal SCs
6.5 Other Sources
7 Stem Cell Therapy Market by Therapeutic Application
7.1 Introduction
7.2 Musculoskeletal Disorders
7.3 neurodegenerative disorders
7.4 Wounds and Injuries
7.5 Cardiovascular Diseases
7.6 Surgeries
7.7 Gastrointestinal Diseases
7.8 Dermatology
7.9 Eye Diseases
7.10 Immune System Diseases
7.11 CNS Diseases
7.12 CVS Diseases
7.13 Other Applications
7.13.1 Acute Graft-Versus-Host Disease (AGVHD)
8 Stem Cell Therapy Market by End-User
8.1 Introduction
8.2 Ambulatory Service Centers
8.3 Hospital
9 Geographical Segmentation
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 South America
9.4.1 Argentina
9.4.2 Brazil
9.4.3 Venezuela
9.4.4 Chile
9.4.5 Peru
9.5 Middle East & Africa
9.5.1 UAE
9.5.2 Saudi Arabia
9.5.3 Qatar
9.5.4 Iran
9.5.5 South Africa
9.5.6 Rest of MEA
10 Vendor Landscaping
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiles
11.1 Cellular Dynamics International
11.2 Osiris Therapeutics
11.3 Vcanbio
11.4 Gamida Cell Ltd.
11.5 Golden Meditech
11.6 Celgene Corporation
11.7 Guanhao Biotech
11.8 Mesoblast
11.9 Vericel Corporation
11.10 Stemcell Technologes
11.11 Beike Biotechnology
11.12 Cytori Therapeutics, Inc.
11.13 Bioheart
11.14 Athersys Inc.
11.15 Geron
11.16 Pluristem Therapeutics Inc
11.17 Fibrocell Science
11.18 Ocata Therapeutics
12 Appendix
13 Disclaimer
List of Tables
Table 1 Global Stem Cell Therapy Market Analysis, by Region, (2016-2025) ($MN)
Table 2 Global Stem Cell Therapy Market Analysis, by Type, (2016-2025) ($MN)
Table 3 Global Stem Cell Therapy Market Analysis, by Allogeneic Stem Cell, (2016-2025) ($MN)
Table 4 Global Stem Cell Therapy Market Analysis, by Autologous Stem Cell, (2016-2025) ($MN)
Table 5 Global Stem Cell Therapy Market Analysis, by Cell Source, (2016-2025) ($MN)
Table 6 Global Stem Cell Therapy Market Analysis, by Embryonic SCs, (2016-2025) ($MN)
Table 7 Global Stem Cell Therapy Market Analysis, by Bone Marrow-Derived Mesenchymal SCs, (2016-2025) ($MN)
Table 8 Global Stem Cell Therapy Market Analysis, by Adipose Tissue-Derived Mesenchymal SCs, (2016-2025) ($MN)
Table 9 Global Stem Cell Therapy Market Analysis, by Other Sources, (2016-2025) ($MN)
Table 10 Global Stem Cell Therapy Market Analysis, by Therapeutic Application, (2016-2025) ($MN)
Table 11 Global Stem Cell Therapy Market Analysis, by Musculoskeletal Disorders, (2016-2025) ($MN)
Table 12 Global Stem Cell Therapy Market Analysis, by neurodegenerative disorders, (2016-2025) ($MN)
Table 13 Global Stem Cell Therapy Market Analysis, by Wounds and Injuries, (2016-2025) ($MN)
Table 14 Global Stem Cell Therapy Market Analysis, by Cardiovascular Diseases, (2016-2025) ($MN)
Table 15 Global Stem Cell Therapy Market Analysis, by Surgeries, (2016-2025) ($MN)
Table 16 Global Stem Cell Therapy Market Analysis, by Gastrointestinal Diseases, (2016-2025) ($MN)
Table 17 Global Stem Cell Therapy Market Analysis, by Dermatology, (2016-2025) ($MN)
Table 18 Global Stem Cell Therapy Market Analysis, by Eye Diseases, (2016-2025) ($MN)
Table 19 Global Stem Cell Therapy Market Analysis, by Immune System Diseases, (2016-2025) ($MN)
Table 20 Global Stem Cell Therapy Market Analysis, by CNS Diseases, (2016-2025) ($MN)
Table 21 Global Stem Cell Therapy Market Analysis, by CVS Diseases, (2016-2025) ($MN)
Table 22 Global Stem Cell Therapy Market Analysis, by Other Applications, (2016-2025) ($MN)
Table 23 Global Stem Cell Therapy Market Analysis, by Acute Graft-Versus-Host Disease (AGVHD), (2016-2025) ($MN)
Table 24 Global Stem Cell Therapy Market Analysis, by End-User, (2016-2025) ($MN)
Table 25 Global Stem Cell Therapy Market Analysis, by Ambulatory Service Centers, (2016-2025) ($MN)
Table 26 Global Stem Cell Therapy Market Analysis, by Hospital, (2016-2025) ($MN)
Table 27 North America Stem Cell Therapy Market Analysis, by Region, (2016-2025) ($MN)
Table 28 North America Stem Cell Therapy Market Analysis, by Type, (2016-2025) ($MN)
Table 29 North America Stem Cell Therapy Market Analysis, by Allogeneic Stem Cell, (2016-2025) ($MN)
Table 30 North America Stem Cell Therapy Market Analysis, by Autologous Stem Cell, (2016-2025) ($MN)
Table 31 North America Stem Cell Therapy Market Analysis, by Cell Source, (2016-2025) ($MN)
Table 32 North America Stem Cell Therapy Market Analysis, by Embryonic SCs, (2016-2025) ($MN)
Table 33 North America Stem Cell Therapy Market Analysis, by Bone Marrow-Derived Mesenchymal SCs, (2016-2025) ($MN)
Table 34 North America Stem Cell Therapy Market Analysis, by Adipose Tissue-Derived Mesenchymal SCs, (2016-2025) ($MN)
Table 35 North America Stem Cell Therapy Market Analysis, by Other Sources, (2016-2025) ($MN)
Table 36 North America Stem Cell Therapy Market Analysis, by Therapeutic Application, (2016-2025) ($MN)
Table 37 North America Stem Cell Therapy Market Analysis, by Musculoskeletal Disorders, (2016-2025) ($MN)
Table 38 North America Stem Cell Therapy Market Analysis, by neurodegenerative disorders, (2016-2025) ($MN)
Table 39 North America Stem Cell Therapy Market Analysis, by Wounds and Injuries, (2016-2025) ($MN)
Table 40 North America Stem Cell Therapy Market Analysis, by Cardiovascular Diseases, (2016-2025) ($MN)
Table 41 North America Stem Cell Therapy Market Analysis, by Surgeries, (2016-2025) ($MN)
Table 42 North America Stem Cell Therapy Market Analysis, by Gastrointestinal Diseases, (2016-2025) ($MN)
Table 43 North America Stem Cell Therapy Market Analysis, by Dermatology, (2016-2025) ($MN)
Table 44 North America Stem Cell Therapy Market Analysis, by Eye Diseases, (2016-2025) ($MN)
Table 45 North America Stem Cell Therapy Market Analysis, by Immune System Diseases, (2016-2025) ($MN)
Table 46 North America Stem Cell Therapy Market Analysis, by CNS Diseases, (2016-2025) ($MN)
Table 47 North America Stem Cell Therapy Market Analysis, by CVS Diseases, (2016-2025) ($MN)
Table 48 North America Stem Cell Therapy Market Analysis, by Other Applications, (2016-2025) ($MN)
Table 49 North America Stem Cell Therapy Market Analysis, by Acute Graft-Versus-Host Disease (AGVHD), (2016-2025) ($MN)
Table 50 North America Stem Cell Therapy Market Analysis, by End-User, (2016-2025) ($MN)
Table 51 North America Stem Cell Therapy Market Analysis, by Ambulatory Service Centers, (2016-2025) ($MN)
Table 52 North America Stem Cell Therapy Market Analysis, by Hospital, (2016-2025) ($MN)
Table 53 Europe Stem Cell Therapy Market Analysis, by Region, (2016-2025) ($MN)
Table 54 Europe Stem Cell Therapy Market Analysis, by Type, (2016-2025) ($MN)
Table 55 Europe Stem Cell Therapy Market Analysis, by Allogeneic Stem Cell, (2016-2025) ($MN)
Table 56 Europe Stem Cell Therapy Market Analysis, by Autologous Stem Cell, (2016-2025) ($MN)
Table 57 Europe Stem Cell Therapy Market Analysis, by Cell Source, (2016-2025) ($MN)
Table 58 Europe Stem Cell Therapy Market Analysis, by Embryonic SCs, (2016-2025) ($MN)
Table 59 Europe Stem Cell Therapy Market Analysis, by Bone Marrow-Derived Mesenchymal SCs, (2016-2025) ($MN)
Table 60 Europe Stem Cell Therapy Market Analysis, by Adipose Tissue-Derived Mesenchymal SCs, (2016-2025) ($MN)
Table 61 Europe Stem Cell Therapy Market Analysis, by Other Sources, (2016-2025) ($MN)
Table 62 Europe Stem Cell Therapy Market Analysis, by Therapeutic Application, (2016-2025) ($MN)
Table 63 Europe Stem Cell Therapy Market Analysis, by Musculoskeletal Disorders, (2016-2025) ($MN)
Table 64 Europe Stem Cell Therapy Market Analysis, by neurodegenerative disorders, (2016-2025) ($MN)
Table 65 Europe Stem Cell Therapy Market Analysis, by Wounds and Injuries, (2016-2025) ($MN)
Table 66 Europe Stem Cell Therapy Market Analysis, by Cardiovascular Diseases, (2016-2025) ($MN)
Table 67 Europe Stem Cell Therapy Market Analysis, by Surgeries, (2016-2025) ($MN)
Table 68 Europe Stem Cell Therapy Market Analysis, by Gastrointestinal Diseases, (2016-2025) ($MN)
Table 69 Europe Stem Cell Therapy Market Analysis, by Dermatology, (2016-2025) ($MN)
Table 70 Europe Stem Cell Therapy Market Analysis, by Eye Diseases, (2016-2025) ($MN)
Table 71 Europe Stem Cell Therapy Market Analysis, by Immune System Diseases, (2016-2025) ($MN)
Table 72 Europe Stem Cell Therapy Market Analysis, by CNS Diseases, (2016-2025) ($MN)
Table 73 Europe Stem Cell Therapy Market Analysis, by CVS Diseases, (2016-2025) ($MN)
Table 74 Europe Stem Cell Therapy Market Analysis, by Other Applications, (2016-2025) ($MN)
Table 75 Europe Stem Cell Therapy Market Analysis, by Acute Graft-Versus-Host Disease (AGVHD), (2016-2025) ($MN)
Table 76 Europe Stem Cell Therapy Market Analysis, by End-User, (2016-2025) ($MN)
Table 77 Europe Stem Cell Therapy Market Analysis, by Ambulatory Service Centers, (2016-2025) ($MN)
Table 78 Europe Stem Cell Therapy Market Analysis, by Hospital, (2016-2025) ($MN)
Table 79 Asia Pacific Stem Cell Therapy Market Analysis, by Region, (2016-2025) ($MN)
Table 80 Asia Pacific Stem Cell Therapy Market Analysis, by Type, (2016-2025) ($MN)
Table 81 Asia Pacific Stem Cell Therapy Market Analysis, by Allogeneic Stem Cell, (2016-2025) ($MN)
Table 82 Asia Pacific Stem Cell Therapy Market Analysis, by Autologous Stem Cell, (2016-2025) ($MN)
Table 83 Asia Pacific Stem Cell Therapy Market Analysis, by Cell Source, (2016-2025) ($MN)
Table 84 Asia Pacific Stem Cell Therapy Market Analysis, by Embryonic SCs, (2016-2025) ($MN)
Table 85 Asia Pacific Stem Cell Therapy Market Analysis, by Bone Marrow-Derived Mesenchymal SCs, (2016-2025) ($MN)
Table 86 Asia Pacific Stem Cell Therapy Market Analysis, by Adipose Tissue-Derived Mesenchymal SCs, (2016-2025) ($MN)
Table 87 Asia Pacific Stem Cell Therapy Market Analysis, by Other Sources, (2016-2025) ($MN)
Table 88 Asia Pacific Stem Cell Therapy Market Analysis, by Therapeutic Application, (2016-2025) ($MN)
Table 89 Asia Pacific Stem Cell Therapy Market Analysis, by Musculoskeletal Disorders, (2016-2025) ($MN)
Table 90 Asia Pacific Stem Cell Therapy Market Analysis, by neurodegenerative disorders, (2016-2025) ($MN)
Table 91 Asia Pacific Stem Cell Therapy Market Analysis, by Wounds and Injuries, (2016-2025) ($MN)
Table 92 Asia Pacific Stem Cell Therapy Market Analysis, by Cardiovascular Diseases, (2016-2025) ($MN)
Table 93 Asia Pacific Stem Cell Therapy Market Analysis, by Surgeries, (2016-2025) ($MN)
Table 94 Asia Pacific Stem Cell Therapy Market Analysis, by Gastrointestinal Diseases, (2016-2025) ($MN)
Table 95 Asia Pacific Stem Cell Therapy Market Analysis, by Dermatology, (2016-2025) ($MN)
Table 96 Asia Pacific Stem Cell Therapy Market Analysis, by Eye Diseases, (2016-2025) ($MN)
Table 97 Asia Pacific Stem Cell Therapy Market Analysis, by Immune System Diseases, (2016-2025) ($MN)
Table 98 Asia Pacific Stem Cell Therapy Market Analysis, by CNS Diseases, (2016-2025) ($MN)
Table 99 Asia Pacific Stem Cell Therapy Market Analysis, by CVS Diseases, (2016-2025) ($MN)
Table 100 Asia Pacific Stem Cell Therapy Market Analysis, by Other Applications, (2016-2025) ($MN)
Table 101 Asia Pacific Stem Cell Therapy Market Analysis, by Acute Graft-Versus-Host Disease (AGVHD), (2016-2025) ($MN)
Table 102 Asia Pacific Stem Cell Therapy Market Analysis, by End-User, (2016-2025) ($MN)
Table 103 Asia Pacific Stem Cell Therapy Market Analysis, by Ambulatory Service Centers, (2016-2025) ($MN)
Table 104 Asia Pacific Stem Cell Therapy Market Analysis, by Hospital, (2016-2025) ($MN)
Table 105 South America Stem Cell Therapy Market Analysis, by Region, (2016-2025) ($MN)
Table 106 South America Stem Cell Therapy Market Analysis, by Type, (2016-2025) ($MN)
Table 107 South America Stem Cell Therapy Market Analysis, by Allogeneic Stem Cell, (2016-2025) ($MN)
Table 108 South America Stem Cell Therapy Market Analysis, by Autologous Stem Cell, (2016-2025) ($MN)
Table 109 South America Stem Cell Therapy Market Analysis, by Cell Source, (2016-2025) ($MN)
Table 110 South America Stem Cell Therapy Market Analysis, by Embryonic SCs, (2016-2025) ($MN)
Table 111 South America Stem Cell Therapy Market Analysis, by Bone Marrow-Derived Mesenchymal SCs, (2016-2025) ($MN)
Table 112 South America Stem Cell Therapy Market Analysis, by Adipose Tissue-Derived Mesenchymal SCs, (2016-2025) ($MN)
Table 113 South America Stem Cell Therapy Market Analysis, by Other Sources, (2016-2025) ($MN)
Table 114 South America Stem Cell Therapy Market Analysis, by Therapeutic Application, (2016-2025) ($MN)
Table 115 South America Stem Cell Therapy Market Analysis, by Musculoskeletal Disorders, (2016-2025) ($MN)
Table 116 South America Stem Cell Therapy Market Analysis, by neurodegenerative disorders, (2016-2025) ($MN)
Table 117 South America Stem Cell Therapy Market Analysis, by Wounds and Injuries, (2016-2025) ($MN)
Table 118 South America Stem Cell Therapy Market Analysis, by Cardiovascular Diseases, (2016-2025) ($MN)
Table 119 South America Stem Cell Therapy Market Analysis, by Surgeries, (2016-2025) ($MN)
Table 120 South America Stem Cell Therapy Market Analysis, by Gastrointestinal Diseases, (2016-2025) ($MN)
Table 121 South America Stem Cell Therapy Market Analysis, by Dermatology, (2016-2025) ($MN)
Table 122 South America Stem Cell Therapy Market Analysis, by Eye Diseases, (2016-2025) ($MN)
Table 123 South America Stem Cell Therapy Market Analysis, by Immune System Diseases, (2016-2025) ($MN)
Table 124 South America Stem Cell Therapy Market Analysis, by CNS Diseases, (2016-2025) ($MN)
Table 125 South America Stem Cell Therapy Market Analysis, by CVS Diseases, (2016-2025) ($MN)
Table 126 South America Stem Cell Therapy Market Analysis, by Other Applications, (2016-2025) ($MN)
Table 127 South America Stem Cell Therapy Market Analysis, by Acute Graft-Versus-Host Disease (AGVHD), (2016-2025) ($MN)
Table 128 South America Stem Cell Therapy Market Analysis, by End-User, (2016-2025) ($MN)
Table 129 South America Stem Cell Therapy Market Analysis, by Ambulatory Service Centers, (2016-2025) ($MN)
Table 130 South America Stem Cell Therapy Market Analysis, by Hospital, (2016-2025) ($MN)
Table 131 Middle East & Africa Stem Cell Therapy Market Analysis, by Region, (2016-2025) ($MN)
Table 132 Middle East & Africa Stem Cell Therapy Market Analysis, by Type, (2016-2025) ($MN)
Table 133 Middle East & Africa Stem Cell Therapy Market Analysis, by Allogeneic Stem Cell, (2016-2025) ($MN)
Table 134 Middle East & Africa Stem Cell Therapy Market Analysis, by Autologous Stem Cell, (2016-2025) ($MN)
Table 135 Middle East & Africa Stem Cell Therapy Market Analysis, by Cell Source, (2016-2025) ($MN)
Table 136 Middle East & Africa Stem Cell Therapy Market Analysis, by Embryonic SCs, (2016-2025) ($MN)
Table 137 Middle East & Africa Stem Cell Therapy Market Analysis, by Bone Marrow-Derived Mesenchymal SCs, (2016-2025) ($MN)
Table 138 Middle East & Africa Stem Cell Therapy Market Analysis, by Adipose Tissue-Derived Mesenchymal SCs, (2016-2025) ($MN)
Table 139 Middle East & Africa Stem Cell Therapy Market Analysis, by Other Sources, (2016-2025) ($MN)
Table 140 Middle East & Africa Stem Cell Therapy Market Analysis, by Therapeutic Application, (2016-2025) ($MN)
Table 141 Middle East & Africa Stem Cell Therapy Market Analysis, by Musculoskeletal Disorders, (2016-2025) ($MN)
Table 142 Middle East & Africa Stem Cell Therapy Market Analysis, by neurodegenerative disorders, (2016-2025) ($MN)
Table 143 Middle East & Africa Stem Cell Therapy Market Analysis, by Wounds and Injuries, (2016-2025) ($MN)
Table 144 Middle East & Africa Stem Cell Therapy Market Analysis, by Cardiovascular Diseases, (2016-2025) ($MN)
Table 145 Middle East & Africa Stem Cell Therapy Market Analysis, by Surgeries, (2016-2025) ($MN)
Table 146 Middle East & Africa Stem Cell Therapy Market Analysis, by Gastrointestinal Diseases, (2016-2025) ($MN)
Table 147 Middle East & Africa Stem Cell Therapy Market Analysis, by Dermatology, (2016-2025) ($MN)
Table 148 Middle East & Africa Stem Cell Therapy Market Analysis, by Eye Diseases, (2016-2025) ($MN)
Table 149 Middle East & Africa Stem Cell Therapy Market Analysis, by Immune System Diseases, (2016-2025) ($MN)
Table 150 Middle East & Africa Stem Cell Therapy Market Analysis, by CNS Diseases, (2016-2025) ($MN)
Table 151 Middle East & Africa Stem Cell Therapy Market Analysis, by CVS Diseases, (2016-2025) ($MN)
Table 152 Middle East & Africa Stem Cell Therapy Market Analysis, by Other Applications, (2016-2025) ($MN)
Table 153 Middle East & Africa Stem Cell Therapy Market Analysis, by Acute Graft-Versus-Host Disease (AGVHD), (2016-2025) ($MN)
Table 154 Middle East & Africa Stem Cell Therapy Market Analysis, by End-User, (2016-2025) ($MN)
Table 155 Middle East & Africa Stem Cell Therapy Market Analysis, by Ambulatory Service Centers, (2016-2025) ($MN)
Table 156 Middle East & Africa Stem Cell Therapy Market Analysis, by Hospital, (2016-2025) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook